Tesaro (TSRO) Faces Near-Term Risks to Key Drug - Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Merck & Co. (NYSE: MRK) | Delayed: 140.32 -3.98 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.30 | 52 Week High | $65.46 | |||
| Open | $143.67 | 52 Week Low | $47.97 | |||
| Day High | $144.06 | P/E | 95.46 | |||
| Day Low | $138.80 | EPS | $1.47 | |||
| Volume | 4,581,770 | |||||
| TESARO (NASDAQ: TSRO) | Delayed: 74.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.96 | 52 Week High | $148.74 | |||
| Open | $25.63 | 52 Week Low | $29.51 | |||
| Day High | $74.96 | P/E | N/A | |||
| Day Low | $74.96 | EPS | $-2.93 | |||
| Volume | 0 | |||||
